Lazard Asset Management
SYRE icon

Lazard Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Lazard Asset Management’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-352
Closed -$69K – 2457
2021
Q3 		$69K Buy
+352
New +$69K ﹤0.01% 1541